Article Details

Ovid Therapeutics (OVID) Rating Lowered to Sell at ValuEngine

Retrieved on: 2019-05-10 00:53:06

Tags for this article:

Click the tags to see associated articles and topics

Ovid Therapeutics (OVID) Rating Lowered to Sell at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP bought a new stake in shares of Ovid Therapeutics during the fourth quarter valued at about $114,000. Dimensional Fund ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo